Baba, Vevencio, JR.. S.

HRN: 14-66-82  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/19/2023
CIPROFLOXACIN 500MG (TAB)
05/20/2023
05/27/2023
ORAL
500 Mg
Q12
Acute Infectious Diarrhea
Waiting Final Action 
05/26/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/26/2023
06/02/2023
IV
4.5g
TID
Empiric
Waiting Final Action 
05/31/2023
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
05/31/2023
06/07/2023
IV
500mg
OD
T/C Sepsis
Waiting Final Action 
06/01/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/02/2023
06/08/2023
IVTT
2.25 G
Q6
CapHR; (antibiotic Extension)
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: